Recent Advancements in Non-Small Cell Lung Cancer
Bilal Piperdi, MD, discusses the recent advancements in non-small cell lung cancer treatment and what the future might bring.
Bilal Piperdi, MD, Associate Professor of Clinical Medicine, Department of Medicine (Oncology), Albert Einstein College of Medicine, discusses the recent advancements in non-small cell lung cancer treatment and what the future might bring.
Clinical Pearls:
- There have been improvements in molecular testing
- Physicians have learned that it is not just the histology that determines the biology of these patients; it is different mutations that define the biology of this disease
- More advances in molecular testing would allow for clinicians to test for multiple mutations at a time, including some of the uncommon mutations
- The challenge in the future will be learning how the different mutations interact and what targets can better treat the cancer
Recent Videos
Related Content
Brahmer Considers First-Line Immunotherapy Options in Metastatic NSCLC
February 17th 2025Article
During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON trials of immunotherapy in patients with metastatic non–small cell lung cancer.
Read More
